Přerov

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease3 trials
• Familial hypercholesterolaemia3 trials
• Stroke2 trials
• Peripheral artery disease1 trial

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

  NCT05192941· Phase 4· Novartis Pharmaceuticals· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Novartis Pharmaceuticals· Source